Figure Legends
Figure 1. Patient 1 had over 50% reduction in size her LM
after a year on alectinib. Sagittal T2 weighted MRI of the lumbar spine
A) prior to alectinib and B) after one year on alectinib. Coronal
gadolinium enhanced T1 weighted MRI of the lumbar spine C) prior to
alectinib and D) after one year on alectinib.
Figure 2. Patient 2 with over 20% reduction in size of the
labial component of her LM after 3 months on crizotinib. Coronal T2
weighted MRI of the pelvis A) at 13 years old prior to crizotinib
therapy, and B) at 17 years old after 3 months on crizotinib therapy.